Skip to content

APOTHEEK VAN HOORICKX: what changed

BE 0479.959.562NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€35,272
2024 · €193+€35,079
Equity
€117,434
2024 · €82,162+€35,272
Cash
€33,462
2024 · €13,403+€20,059
Balance sheet total
€579,253
2024 · €267,425+€311,827

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€267,669

    up €267,669 (+178%), from €150,414 to €418,083

    of which Other amounts receivable: +€294,769

  • Stocks and contracts +€29,519

    up €29,519 (+31.9%), from €92,466 to €121,985

  • Cash +€20,059

    up €20,059 (+150%), from €13,403 to €33,462

    mainly Short-term financial debts (+€225,900) and Trade debts (+€69,147)

  • Deferred charges and accrued income -€7,917

    down €7,917 (-89.9%), from €8,806 to €890

Equity and liabilities
  • Short-term financial debts +€225,900

    first reported in 2025, at €225,900

    of which Credit institutions: +€200,000

  • Reserves +€93,753

    up €93,753 (+1,845%), from €5,081 to €98,834

    of which Distributable reserves: +€93,753

  • Trade debts +€69,147

    up €69,147 (+66.6%), from €103,866 to €173,013

  • Debts after one year +€62,900

    first reported in 2025, at €62,900

  • Profit (loss) carried forward -€58,481

    down €58,481 (-100%), from €58,481 to €0

Income statement
  • Staff costs -€48,777

    down €48,777 (-57.0%), from €85,599 to €36,822

  • Gross operating margin -€12,825

    down €12,825 (-14.5%), from €88,197 to €75,372

  • Financial charges +€3,762

    up €3,762 (+357%), from €1,055 to €4,817

  • Financial income +€1,861

    up €1,861 (+99.3%), from €1,875 to €3,737

  • Depreciation -€1,192

    down €1,192 (-52.6%), from €2,265 to €1,073

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €193
Gross operating margin -€12,825
Staff costs +€48,777
Depreciation +€1,192
Other operating charges -€165
Financial income +€1,861
Financial charges -€3,762
Result 2025 €35,272
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€265,171
Investment -€3,570
Financing +€288,800
Cash 2024 €13,403
Net result for the year +€35,272
Depreciation +€1,073
Stocks and contracts -€29,519
Receivables within one year -€267,669
Deferred charges and accrued income +€7,917
Trade debts +€69,147
Tax, wage and social debts -€20,801
Other debts -€42,486
Accrued charges and deferred income -€18,105
Investment in fixed assets (net) -€3,570
Debts after one year +€62,900
Short-term financial debts +€225,900
Cash 2025 €33,462
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €267,425 €579,253 +€311,827 +117%
Fixed assets 21/28 €2,336 €4,833 +€2,497 +107%
Tangible fixed assets 22/27 €2,336 €4,833 +€2,497 +107%
Plant, machinery and equipment 23 €2,336 €4,833 +€2,497 +107%
Current assets 29/58 €265,090 €574,420 +€309,330 +117%
Stocks and contracts in progress 3 €92,466 €121,985 +€29,519 +31.9%
Stocks 30/36 €92,466 €121,985 +€29,519 +31.9%
Amounts receivable within one year 40/41 €150,414 €418,083 +€267,669 +178%
Trade receivables 40 €149,657 €122,557 -€27,099 -18.1%
Other amounts receivable 41 €757 €295,526 +€294,769 +38,924%
Cash at bank and in hand 54/58 €13,403 €33,462 +€20,059 +150%
Deferred charges and accrued income 490/1 €8,806 €890 -€7,917 -89.9%
Total equity and liabilities 10/49 €267,425 €579,253 +€311,827 +117%
Equity 10/15 €82,162 €117,434 +€35,272 +42.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €5,081 €98,834 +€93,753 +1,845%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €3,221 €96,974 +€93,753 +2,910%
Profit (loss) carried forward 14 €58,481 €0 -€58,481 -100%
Amounts payable 17/49 €185,263 €461,818 +€276,555 +149%
Amounts payable after more than one year 17 - €62,900 +€62,900
Financial debts 170/4 - €62,900 +€62,900
Amounts payable within one year 42/48 €167,158 €398,918 +€231,760 +139%
Financial debts 43 - €225,900 +€225,900
Credit institutions 430/8 - €200,000 +€200,000
Other loans 439 - €25,900 +€25,900
Trade debts 44 €103,866 €173,013 +€69,147 +66.6%
Suppliers 440/4 €103,866 €173,013 +€69,147 +66.6%
Taxes, remuneration and social security 45 €20,801 €0 -€20,801 -100%
Taxes 450/3 €4,088 €0 -€4,088 -100%
Remuneration and social security 454/9 €16,713 €0 -€16,713 -100%
Other amounts payable 47/48 €42,491 €5 -€42,486 -100.0%
Accrued charges and deferred income 492/3 €18,105 €0 -€18,105 -100%
Remuneration, social security and pensions 62 €85,599 €36,822 -€48,777 -57.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,265 €1,073 -€1,192 -52.6%
Other operating charges 640/8 €960 €1,125 +€165 +17.2%
Gross operating margin 9900 €88,197 €75,372 -€12,825 -14.5%
Operating profit (loss) 9901 -€627 €36,352 +€36,979
Financial income 75/76B €1,875 €3,737 +€1,861 +99.3%
Recurring financial income 75 €1,875 €3,737 +€1,861 +99.3%
Financial charges 65/66B €1,055 €4,817 +€3,762 +357%
Recurring financial charges 65 €1,055 €4,817 +€3,762 +357%
Profit (loss) for the period before taxes 9903 €193 €35,272 +€35,079 +18,166%
Profit (loss) for the period 9904 €193 €35,272 +€35,079 +18,166%
Profit (loss) for the period to be appropriated 9905 €193 €35,272 +€35,079 +18,166%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€98,307 to €114,142

Midpoint €104,905 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €117,434
Capitalised earnings €79,179 to €110,850
Indication €98,307 to €114,142

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€117,434
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€117,434

Capitalised earnings

net result for the year (9904)
2025
€35,272
2024
€193
2023
-€2,211
2022
-€13,839
2021
-€25,088
Average result
€11,085
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€79,179 / €92,375 / €110,850

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.